Demystifying Select Medical Hldgs: Insights From 4 Analyst Reviews
Portfolio Pulse from Benzinga Insights
Over the past three months, four analysts have evaluated Select Medical Holdings (NYSE:SEM), with the majority being bullish. The average 12-month price target has increased to $44.5, reflecting a 7.88% rise. Analysts from Benchmark and RBC Capital have raised their price targets, indicating positive sentiment. Despite strong financial metrics like net margin and ROE, the company faces challenges with a high debt-to-equity ratio.
August 02, 2024 | 6:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Select Medical Holdings (NYSE:SEM) has received predominantly bullish ratings from analysts over the past three months. The average 12-month price target has increased to $44.5, reflecting a 7.88% rise. Analysts from Benchmark and RBC Capital have raised their price targets, indicating positive sentiment. Despite strong financial metrics like net margin and ROE, the company faces challenges with a high debt-to-equity ratio.
The majority of analysts have given bullish ratings, and the average price target has increased, indicating positive sentiment. However, the high debt-to-equity ratio poses a financial risk.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100